Global Cancer Drugs Market expected to reach USD 161.30

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Global Cancer Drugs Market expected to reach USD 161.30 Billion by 2021: Zion Market Research

Sarasota, FL, Dec. 12, 2016 (GLOBE NEWSWIRE) -- Zion Research has published a new report titled “Cancer Drugs Market by Therapy (Immunotherapy, Targeted Therapy, Chemotherapy, Hormone Therapy and Others) for Breast Cancer, Blood Cancer, Gastrointestinal Cancer, Prostate Cancer, Skin Cancer, Lung Cancer and Other Cancer: Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 - 2021” . According to the report, global demand for  cancer drugs market  was valued at approximately USD 112.90 billion in 2015 and is expected to generate revenue of around USD 161.30 billion by end of 2021, growing at a CAGR of around 7.4% between 2016 and 2021. 

Cancer is defined as a disease which occurs as a result of changes in a group of normal cells within the body which leads to uncontrolled growth resulting in the formation of lump called a tumor; (except for cancer of the blood). If left untreated, tumors can grow and spread into the surrounding normal tissue, or to other parts of the body via lymphatic systems and the bloodstream, and can in turn severely impact the functioning of the digestive, nervous and circulatory systems.

Browse through 27 Market Tables and 25 Figures spread over 110 Pages and in-depth TOC on “Global Cancer Drugs Market: Type, Size, Share, Trends, Review, Analysis, Segment, and Forecast 2015-2021”.

Request free Sample copy of Cancer Drugs Market Report @ https://www.zionmarketresearch.com/sample/can...ugs-market

Global cancer drugs market is primarily driven by growing incidences of target disease such as lung cancer, breast cancer, cervical cancer, etc. across the globe. Other major driving factors are increasing research and development on biological and targeted drug therapies for the treatment of cancer coupled along with the expiration of patents. However, the high price of drug development and stringent regulatory policies coupled along with the possibility of failure are the major restraints that may limit the growth of the market. Nonetheless increasing focus on personalized medicine coupled along with huge investment in anti-cancer drugs research across the globe is likely to disclose the new avenues for cancer drugs market in the near future.

The cancer drugs market is segmented on the basis of the different therapeutic segment including immunotherapy, targeted therapy, chemotherapy, hormone therapy and others. Immunotherapy segment is expected to grow at fastest rate in the global market over the forecast period.

Browse the full " Cancer Drugs Market by Therapy (Immunotherapy, Targeted Therapy, Chemotherapy, Hormone Therapy and Others) for Breast Cancer, Blood Cancer, Gastrointestinal Cancer, Prostate Cancer, Skin Cancer, Lung Cancer and Other Cancer: Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 - 2021 " report at  https://www.zionmarketresearch.com/report/can...ugs-market

Breast cancer, blood cancer, gastrointestinal cancer, prostate cancer, skin cancer, lung cancer and others are the key cancer types of the global cancer drugs market. The blood cancer segment dominated the market in terms of revenue. 

North America represents developed regional markets for cancer drugs and is expected to see the rapid growth in the years to come. The U.S. is by far the leading cancer drugs market by country in North America. The U.S. market is expected to grow at the highest CAGR during the forecast period. This growth is mainly due to the well-developed healthcare infrastructure and the increase in research and development on cancer drugs. Moreover, the disposable income and reimbursement of life-threatening diseases are very high in this region which promotes the growth of cancer drugs market. 

Inquire more about this report @ https://www.zionmarketresearch.com/inquiry/ca...ugs-market

Europe was the second largest regional market and is expected to show significant growth in the years to come. This growth is mainly due to increase in a number of patients diagnosed with cancer.

Asia-Pacific is expected to witness noticeable growth in the near future. In Asia, China, India, and Japan will continue to be the fastest growing markets in cancer drugs market. Growth in Asia-Pacific market is expected to be driven by increasing tobacco consumption, growing population, and increasing disposable income.

Request a customized copy of report @ https://www.zionmarketresearch.com/custom/490

Some of the key players in cancer drugs market include Bayer, GlaxoSmithKline, Novartis, Sanofi and Pfizer, Amgen, Merck, Bristol-Myers Squibb, Celgene Corporation, Ariad Pharmaceuticals, Eli Lilly, Hoffmann-La Roche Ltd, Boehringer Ingelheim GmbH, Johnson and Johnson and Teva Pharmaceuticals among others.

Purchase a direct copy of report with TOC @ https://www.zionmarketresearch.com/buynow/su/...ugs-market

This report segments the global cancer drugs market as follows: Global Cancer Drugs Market: Therapy Segment Analysis

  • Immunotherapy
  • Targeted Therapy
  • Chemotherapy
  • Hormone Therapy
  • Others

Global Cancer Drugs Market: Application Segment Analysis.

  • Breast Cancer
  • Blood Cancer
  • Gastrointestinal Cancer
  • Prostate Cancer
  • Skin Cancer
  • Lung Cancer
  • Others

Global Cancer Drugs Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

Related Reports:

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Follow Us LinkedIn: https://www.linkedin.com/company/zion-market-research

Follow Us Twitter: https://twitter.com/zion_research

Contact Us: Joel John 4283, Express Lane, Suite 634-143, Sarasota, Florida 34249, United States Tel: +49-322 210 92714 USA/Canada Toll-Free No.1-855-465-4651 Email: sales@zionmarketresearch.com Website: https://www.zionmarketresearch.com/

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Bybit Expands ByPick Game with Broader Market Reach

Updated Category News Views 117

Bybit Plays the Game of Expansion Step right up to Bybit’s latest offering – ByPick Season 2. Some folks might be scratching their heads about what's shifting in this free-to-play space, but here we are, watching a beast that’s a mix between a carnival game and a hedge fund playpen. No money exchanged, just knowledge on the line. That's right, we're diving into a...

Continue Reading
Ani Huang: NAHR Fellow Elevates HR Leadership Standards

Updated Category News Views 177

Spotlight on Ani Huang's HR Leadership In a world where corporate strategies and workforce dynamics continually evolve, Ani Huang's ascent to Fellow of the National Academy of Human Resources (NAHR) signals a pivotal recognition. It's not just another pat on the back; it's a validation of a career steered by determination, expertise, and a knack for navigating the tangled...

Continue Reading
WeFetch AI: A New Era in Barcode Precision

Updated Category News Views 140

WeFetch AI: What's in a Name? Forget about GreenCore Solutions Corp. We're talking about WeFetch AI Corp. now. They've just changed their name, fulfilling a bureaucratic tick as of November 13, 2026. But it ain't just a name change; it's a whole new ballgame in AI-driven commerce. AI Shopping Without the Guesswork We've all been there. You think you've ordered that...

Continue Reading
Biodiversity Monitoring Poised for $11.39 Billion Boom

Updated Category News Views 172

A Billion-Dollar Market on the Rise Picture this: you're watching the world make a monumental shift towards sustainability in real-time. The biodiversity monitoring market is on a gallop, poised to grow from a modest USD 7.17 billion in 2026 to a hearty USD 11.39 billion by 2031. That's a CAGR of 9.7%—a pace that soothes the nerves of any investor weary of the whims of...

Continue Reading
Common ADHD Accommodations Fail to Boost Performance

Updated Category News Views 144

Rethink ADHD Accommodations When it comes to ADHD, everyone ties the classic school accommodations to success. You give kids extra time, a quieter spot, and regular breaks, and you figure that's the magic formula, right? Well, hold onto your hats, because a fresh study out of Florida International University is flipping that script. Turns out, all those accommodations we...

Continue Reading
MV Transportation Celebrates Leadership Nomination for FTA

Updated Category News Views 22

MV Throws Support Behind Aesch for FTA Role In this wild world where public transit feels the heat from financial burdens, MV Transportation's recent move to support Mark Aesch for the Federal Transit Administration's top spot isn’t just a nod of approval—it's a full-blown trumpet blast. They're not just doling out a basic endorsement here; they're practically waving...

Continue Reading
First Horizon's $25M Bet: New Center Transforms Houston

Updated Category News Views 127

New Markets Tax Credits: A Game Changer First things first, if you're thinking this is some typical charitable write-off, think again. First Horizon Bank (NYSE: FHN) is deep in the mix of something pretty transformative in the world of finance and community support. They're not just throwing money at a problem and hoping it sticks. Nope, we're talking real strategy with a...

Continue Reading
AppLovin Faces Serious Investor Lawsuit Deadline

Updated Category News Views 143

Investors' Trust Shaken: The AppLovin Controversy Well, what do we have here? Another day, another hefty lawsuit coming down the pike. The spotlight’s on AppLovin Corporation (NASDAQ: APP), where the Hagens Berman law sharks are sniffing blood in the water over what they claim are federal securities law violations. The core of this legal storm swirls around AppLovin's...

Continue Reading
Fly-E Faces Revenue Drop Amid Retail Restructuring

Updated Category News Views 131

Downturn Despite Strategic Restructuring Today, we're diving into Fly-E Group, Inc. (NASDAQ:FLYE) and the latest shakeup in their financials—spoiler alert, it's riding a downward slope. Quarter two of fiscal 2027 didn't exactly shine a light on profitability. Net revenues slid, dropping to $2.6 million this quarter, down from $3.9 million the previous year. Tack that up...

Continue Reading
Timken Maintains Robust Dividend Streak in 2026

Updated Category News Views 134

Timken Keeps Dividend Train Rolling You want to talk consistency? Timken Company just declared its quarterly dividend like clockwork. As a stockholder, that might just be your morning coffee fix before anything else. Notably, Timken's been on the NYSE since 1922, having cranked out 418 consecutive dividend payouts. That's like your grandpa never missing a Sunday golf...

Continue Reading

Top 5 Most Recently Viewed Articles

Celebrating 30 Years: Feminist Leaders Forge a New Path

Updated Category News Views 129

Feminist Leaders Gather for a New Chapter in Feminism An inspiring gathering of feminist trailblazers explored the future of feminist strategies, narrative power, and the evolution of feminist media. Reflecting on Feminism's Growth Feminist.com recently commemorated its impressive three-decade journey with a special salon hosted in the iconic home of Gloria Steinem, a key...

Continue Reading
Scott Bessent's Strategic Shift: What Comes Next for Bitcoin?

Updated Category News Views 150

U.S. Treasury's New Direction on Bitcoin Acquisitions U.S. Treasury Secretary Scott Bessent has recently shared important updates regarding the government's stance on Bitcoin holdings. During a public statement, Bessent clarified that the government will no longer be acquiring additional Bitcoin for its strategic reserve. Instead, he stated that the only way the holdings...

Continue Reading
Sensus Healthcare Faces Legal Scrutiny Amid Declining Revenue

Updated Category News Views 184

Understanding the Current Situation of Sensus Healthcare Sensus Healthcare, Inc. has recently attracted the attention of legal experts as the company navigates through troubling financial results. This examination is critical for stockholders who may be wondering about their investment’s future. Established in the healthcare sector, the company specializes in innovative...

Continue Reading
Market Gains on Micron's Surge and China’s Stimulus Moves

Updated Category News Views 165

Micron, Inc. (NASDAQ: MU) has sparked quite the buzz on Wall Street following its recent earnings announcement. The report didn’t just meet expectations; it lit a fire under the stock, which surged over 15% in premarket trading. This performance signals a potential shift in market momentum that traders have been eagerly awaiting. The global markets seem to be catching...

Continue Reading
MetaRouter Appoints Nikhil Raj as New CEO for AI-Driven Growth

Updated Category News Views 285

MetaRouter Announces Nikhil Raj as New CEO MetaRouter, a leader in enterprise-grade customer data infrastructure, recently announced the appointment of Nikhil Raj as its new Chief Executive Officer. This move marks an important transition for the company as it embarks on its upcoming growth phase, aimed at empowering businesses to navigate the complexities of AI...

Continue Reading